Evidence map›Paper›PMID 41676251›Full record

ArticleAmerican journal of translational research2026

Comparison of clinical therapeutic effects between high-flux dialysis and low-flux dialysis.

Yunyi Li, Xianggeng Chi, Rui Cao, Xiaofan He, Ao-Ieong Chi-Wa, Chen Yun, Lifeng Yang, Huanhuan Liu, Shouping Zhu, Yihan Wang and 13 more

Abstract read
In one paragraph

Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yunyi LiDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Xianggeng ChiDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Rui CaoDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Xiaofan HeGuangdong Medical Devices Quality Surveillance and Test Institute Guangzhou 510663, Guangdong, China.
Ao-Ieong Chi-WaKiang Wu Hospital Macao 820002, China.
Chen YunXidian University, Guangzhou Institute of Technology Guangzhou 510555, Guangdong, China.
Lifeng YangGuangdong Medical Devices Quality Surveillance and Test Institute Guangzhou 510663, Guangdong, China.
Huanhuan LiuDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Shouping ZhuXidian University, Guangzhou Institute of Technology Guangzhou 510555, Guangdong, China.
Yihan WangXidian University, Guangzhou Institute of Technology Guangzhou 510555, Guangdong, China.
Huiyi ZengDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Donghao HeDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Ting XieDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Yingming GuThe Second Affiliated Hospital of Guangzhou Medical University Guangzhou 510260, Guangdong, China.
Shuifu TangThe First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine Guangzhou 510405, Guangdong, China.
Weilong LiDepartment of Nephrology, Shenzhen Longhua District Central Hospital Shenzhen 518000, Guangdong, China.
Zhuoheng SongDepartment of Nephrology, Shenzhen Longhua District Central Hospital Shenzhen 518000, Guangdong, China.
Shaodong LuanDepartment of Nephrology, Shenzhen Longhua District Central Hospital Shenzhen 518000, Guangdong, China.
Wenyu GongDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Aiyun ZhaDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Suhua XuGuangdong Medical Devices Quality Surveillance and Test Institute Guangzhou 510663, Guangdong, China.
Huixia YuDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.
Lianghong YinDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University Guangzhou 510632, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the efficacy of, as well as effects on micro-inflammatory and metabolic acidosis between high-flux and low-flux dialysis in the hemodialysis population.

methodsThis multicenter retrospective cohort study, based on pre-defined blood sample data completeness criteria, screened and included treatment records of 187 patients undergoing high-flux dialysis and 189 patients undergoing low-flux dialysis from 2016 to 2018. Ultimately, 374 dialysis sessions meeting the completeness criteria from the high-flux group and 378 sessions from the low-flux group were included in the analysis. Baseline characteristics, clinical tolerance, dialysis efficiency, serum laboratory parameters, micro-inflammatory status, and metabolic acidosis indicators were compared between the two groups.

resultsBoth groups exhibited good biocompatibility, with effective removal of excess water and uremic toxins from the body. Contrastingly, high-flux dialysis was better than low-flux dialysis in removing moderate and small molecule toxins, maintaining blood pressure and acid-base balance in the body.

conclusionsThe study provides useful insights into the comparative efficacy, micro-inflammation, and metabolic acidosis of high-flux and low-flux dialysis. These findings support the preferential use of high-flux dialysis to enhance solute clearance and correct acidosis, while affirming that both modalities are well-tolerated. The choice should be individualized based on patient characteristics and treatment goals.

Indexed as

clinical therapeutic effectHemodialysishigh-flux dialyzerlow-flux dialyzerpolyethersulfone membrane

Identifiers

PMID41676251
PMCPMC12886103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.